Improving sleep regularity to reduce cardiovascular risks in type 1 diabetes
Official title: Circadian Mechanisms of Glycemic Control and Cardiovascular Risk in Adults With Type 1 Diabetes
Run by University of Illinois Chicago · NCT06624046 · Data updated 2026-11-12
This study is trying to see if improving sleep patterns can help adults with type 1 diabetes lower their risk of heart problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | March 13, 2025 |
| Main results expected | February 28, 2029 |
| Study ends | August 31, 2029 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT06624046 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-50 with a clinical diagnosis of type 1 diabetes for at least one year and who experience habitual sleep irregularity.
✕Probably not a fit
Patients with severe hypoglycemia history, significant medical comorbidities, or those using sleep medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between sleep regularity and cardiovascular disease risk in adults with type 1 diabetes (T1D). It aims to understand how enhancing sleep stability through behavioral interventions can improve glycemic control and reduce cardiovascular risks. The study will involve a 4-week intervention targeting sleep stability in 80 participants, examining the mechanisms by which sleep impacts metabolic health. The findings could provide insights into effective strategies for managing T1D and associated cardiovascular risks.
Why it matters
Potential benefit: If successful, this study could lead to improved cardiovascular health and glycemic control for patients with type 1 diabetes.
How similar studies have gone: Previous studies have shown promising results in improving glycemic control through sleep interventions, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults 18-50 years with a clinical diagnosis of T1D for at least one year * Report habitual sleep irregularity ≥1 hour/week * Desire to improve sleep, and own a smartphone (Android or iPhone) Exclusion Criteria: * Self-reported A1C within the past 6 months ≥10% * insomnia symptoms defined as Insomnia Severity Index score ≥15 * history of restless leg syndrome * history of severe hypoglycemia (defined as hypoglycemic episode that results in loss of consciousness, seizure, or requiring emergency room visit or hospitalization) within the past 6 months * rotating shift or night work or routinely sleeping after 3 AM. * use of sleep medications/aids, significant medical comorbidities (such as heart failure, cirrhosis, chronic obstructive pulmonary disease requiring oxygen, active treatment for cancer, on renal replacement therapy \[dialysis\]) * depression (Patient Health Questionnaire 8 \[PHQ-8\] score ≥15) * history of stroke with neurological deficits * pregnant, breast feeding, or planning pregnancy, as sleep and glucose are known to change during pregnancy and breastfeeding. * Allergy to lidocaine Participants who passed the first screen by phone will be scheduled for a consenting visit at UIC
Where it's running
-
University of Illinois Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Pamela Martyn-Nemeth, PhD
- Email: pmartyn@uic.edu
- Phone: 312-996-7903
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic
This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
Dietary changes to help adults with Type 1 diabetes and overweight see if moderate carbs, time-restricted eating, or regular calories work
We’re testing three weight-loss approaches in adults with type 1 diabetes who are overweight or obese to see which helps reduce weight safely.
-
Islet re-transplantation after prior graft failure in adults with type 1 diabetes
This study looks at whether giving another islet transplant after a prior failed graft helps adults with type 1 diabetes who have severe swings in blood sugar.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.